Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological Society of Australia (GESA)

被引：0

作者：

Mitrev, N. ^{[1
]}

Vande Casteele, N. ^{[20
]}

Seow, C. ^{[21
]}

Andrews, J. M. ^{[9
]}

Connor, S. J. ^{[2
]}

Moore, G. ^{[13
]}

Barclay, M. ^{[22
]}

Begun, J. ^{[16
]}

Bryant, R. ^{[11
]}

Chan, W. ^{[1
]}

Corte, C. ^{[19
]}

Ghaly, S. ^{[3
]}

Lemberg, D. A. ^{[4
]}

Kariyawasam, V. ^{[1
]}

Lewindon, P. ^{[17
]}

Martin, J. ^{[7
,8
]}

Mountifield, R. ^{[12
]}

Radford-Smith, G. ^{[18
]}

Slobodian, P. ^{[10
]}

Sparrow, M. ^{[14
]}

Toong, C. ^{[5
,6
]}

Van Langenberg, D. ^{[15
]}

Ward, M. G.

Leong, R. W. ^{[1
]}

机构：

[1] Concord Repatriat Gen Hosp, Concord Hosp, IBD Serv, Sydney, NSW, Australia

[2] Liverpool Hosp, Dept Gastroenterol, Sydney, NSW, Australia

[3] St Vincents Hosp, Dept Gastroenterol, Sydney, NSW, Australia

[4] Sydney Childrens Hosp, Childrens Inflammatory Bowel Dis Clin, Sydney, NSW, Australia

[5] Liverpool Hosp, Sydney South West Pathol Serv, Sydney, NSW, Australia

[6] Concord Repatriat Gen Hosp, Sydney, NSW, Australia

[7] Univ Newcastle, Newcastle, NSW, Australia

[8] Hunter New England Hlth, Newcastle, NSW, Australia

[9] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia

[10] Royal Adelaide Hosp, Pharm Invest Drugs Serv, Adelaide, SA, Australia

[11] Queen Elizabeth Hosp, IBD Serv, Adelaide, SA, Australia

[12] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia

[13] Monash Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia

[14] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia

[15] Box Hill Hosp, Eastern Hlth, IBD Serv, Dept Gastroenterol, Melbourne, Vic, Australia

[16] Mater Hosp Brisbane, Dept Gastroenterol, Brisbane, Qld, Australia

[17] Lady Cilento Childrens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia

[18] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[19] Royal Prince Alfred Hosp, Dept Gastroenterol, Sydney, NSW, Australia

[20] Univ Calif San Diego, San Diego, CA 92103 USA

[21] Univ Calgary, Div Gastroenterol & Hepatol, Calgary, AB, Canada

[22] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：136 / 138

页数：3

共 50 条

[31] Clinical Outcomes of Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Reznicek, Emily
Moafa, Ghady
Barnette, Brooke
Montane, Bryce
Ghouri, Yezaz
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S772 - S772
[32] Therapeutic drug monitoring in inflammatory bowel disease: A practical approach
Devendra Desai
[J]. Indian Journal of Gastroenterology, 2024, 43 : 93 - 102
[33] Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease.
Pugliese, Daniela
Privitera, Giuseppe
Pizzolante, Fabrizio
Gasbarrini, Antonio
Guidi, Luisa
Armuzzi, Alessandro
[J]. MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (04) : 280 - 290
[34] Therapeutic Drug Monitoring-guided High-dose Infliximab for Infantile-onset Inflammatory Bowel Disease: A Case Series
Assa, Amit
Dorfman, Lev
Shouval, Dror S.
Shamir, Raanan
Cohen, Shlomi
[J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (04): : 516 - 520
[35] Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
Albader, Farah
Golovics, Petra Anna
Gonczi, Lorant
Bessissow, Talat
Afif, Waqqas
Lakatos, Peter Laszlo
[J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (37) : 6231 - 6247
[36] Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
Farah Albader
Petra Anna Golovics
Lorant Gonczi
Talat Bessissow
Waqqas Afif
Peter Laszlo Lakatos
[J]. World Journal of Gastroenterology, 2021, 27 (37) : 6231 - 6247
[37] Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?
Papamichael, Konstantinos
Cheifetz, Adam S.
[J]. CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (04) : 302 - 310
[38] New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Khan, Afrasyab
Berahmana, Arvenia B.
Day, Andrew S.
Barclay, Murray L.
Schultz, Michael
[J]. NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1491) : 46 - 62
[39] Drug monitoring of biologics in inflammatory bowel disease
Eser, Alexander
Primas, Christian
Reinisch, Walter
[J]. CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 391 - 396
[40] Uptake of drug monitoring of infliximab and adalimumab in inflammatory bowel disease in Australia
Janko, N.
Little, R. D.
Sparrow, M. P.
Gibson, P. R.
Ward, M. G.
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 136 - 137

← 1 2 3 4 5 →